DHX15 and acute myeloid leukemia: To determine the features of DHX15, we generated point mutants targeting amino acid residues that are predicted to form an RNA binding pocket based on DHX15 crystal structure [74] and R222 residue that is mutated in AML patients and needed for splicing [75] (Figure 7A).